Rapporto sull’analisi delle dimensioni del mercato e delle quote del mercato Leucaferesi | Previsioni 2031

  • Report Code : TIPRE00005515
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 190
Buy Now

[Rapporto di ricerca] Si prevede che il mercato della leucaferesi raggiungerà i 133,90 milioni di dollari entro il 2028, rispetto ai 74,48 milioni di dollari del 2021; si stima che crescerà a un CAGR dell'8,7% dal 2021 al 2028.

La leucaferesi è una procedura che coinvolge i globuli bianchi (leucociti) nella risposta immunitaria dell'organismo vengono separati da un campione di sangue. Si tratta di una particolare forma di aferesi in cui si preleva un elemento del sangue, come i globuli rossi o le piastrine, mentre il sangue rimanente viene rimesso in circolo. La leucaferesi viene spesso utilizzata per ridurre conteggi molto elevati di globuli bianchi (WBC), come i tumori cronici del sangue come la leucemia linfocitica cronica (LLC). Può anche essere completato per ottenere globuli bianchi per un successivo trapianto, ad esempio per gestire bruschi diminuzioni della conta leucocitaria durante la chemioterapia antitumorale. Un altro uso è come parte di una nuova forma di immunoterapia, denominata terapia con cellule T del recettore dell’antigene chimerico (CAR), per aiutare a combattere la leucemia, il cancro alla prostata e altre forme di cancro. La leucaferesi può essere eseguita sulla persona che richiede il trattamento (aferesi autologa) o su un donatore per un successivo trapianto (aferesi allogenica). Attualmente, la leucaferesi è comunemente usata per trattare varie malattie e viene utilizzata anche per scopi diagnostici poiché può aumentare la resa delle cellule tumorali circolanti. Fattori come il numero crescente di donatori di sangue volontari, la crescente incidenza di malattie ematologiche e l’aumento della popolazione anziana stanno alimentando la crescita del mercato della leucaferesi. Tuttavia, il costo elevato della leucaferesi ostacola in una certa misura la crescita del mercato.

Regioni redditizie per il mercato della leucaferesi


Market Insights

La trasfusione di sangue è parte integrante dell'infrastruttura sanitaria nazionale e delle politiche di vari paesi. I progressi nel settore medico hanno portato a miglioramenti nelle procedure di trattamento di malattie gravi e lesioni, che alla fine hanno spinto la necessità di trasfusioni di sangue per i pazienti. sopravvivenza. La crescente consapevolezza dell’importanza delle trasfusioni di sangue e della disponibilità di sangue nei servizi sanitari ha portato ad un aumento del numero di persone disposte a donare il proprio sangue per cause mediche. Secondo i dati dell’Organizzazione Mondiale della Sanità (OMS), nel 2018 sono state segnalate circa 117,4 milioni di donazioni di sangue in tutto il mondo. I donatori di sangue sono generalmente classificati come donatori volontari non retribuiti, retribuiti e familiari/sostitutivi e, secondo le affermazioni dell’OMS, donatori volontari/non retribuiti. sono la principale fonte di un apporto affidabile e adeguato di sangue. Secondo i dati dell’OMS nel 2019, le donazioni di sangue da parte di donatori volontari non retribuiti sono aumentate di 11,6 milioni dal 2008 al 2015 in 139 paesi del mondo. La tendenza alla donazione di sangue sta guadagnando importanza significativa anche nei paesi a basso e medio reddito. Secondo i dati presentati durante l’incontro annuale della CDO del 2017, nel 2016 sono state eseguite circa 13.000 procedure su 1.087 pazienti. L’aumento maggiore nel numero di donatori di sangue volontari è stato riscontrato nei paesi del Sud-est asiatico (83%) e nelle Americhe (70%). .

I programmi nazionali sviluppati e implementati in molti paesi stanno attirando ulteriormente un gran numero di donatori di piastrine e di sangue. Ad esempio, in India, il Consiglio nazionale per le trasfusioni di sangue (NBTC), costituito all'interno della Organizzazione nazionale per il controllo dell'AIDS (NACO), è l'organismo centrale che si coordina con i Consigli statali per le trasfusioni di sangue (SBTC), istituiti all'interno delle società statali per il controllo dell'AIDS. (SACS). L'NBTC sostiene programmi sanitari per varie attività legate ai servizi trasfusionali di sangue (BTS). Pertanto, il numero crescente di donatori idonei in diversi paesi in tutto il mondo sta favorendo la necessità di apparecchiature per leucaferesi utilizzate per separare i componenti del sangue necessari.

Tipo di prodotto- Approfondimenti basati

In base al tipo di prodotto, il mercato della leucaferesi è suddiviso in dispositivi per leucaferesi e materiali monouso per leucaferesi. Nel 2021, il segmento dei prodotti monouso per leucaferesi deteneva una quota di mercato maggiore. Tuttavia, si prevede che il segmento dei dispositivi per leucaferesi registrerà un CAGR più elevato tra il 2021 e il 2028.

Mercato della leucaferesi, per tipo di prodotto– 2021 e 2028

Approfondimenti basati sull'applicazione

Il mercato della leucaferesi, per applicazione, è biforcato in applicazioni di ricerca e applicazioni terapeutiche applicazioni. Nel 2021, il segmento delle applicazioni di ricerca deteneva una quota maggiore del mercato e si prevede che lo stesso segmento registrerà un CAGR più elevato nei prossimi anni.

Utente finale- Approfondimenti basati

Il mercato della leucaferesi, in base all'utente finale, è segmentato in aziende farmaceutiche e biotecnologiche, istituti accademici e di ricerca, fornitori di componenti sanguigni e centri trasfusionali, nonché ospedali e centri trasfusionali. Nel 2021, il segmento dei fornitori di componenti sanguigni e dei centri trasfusionali deteneva la quota maggiore del mercato. D'altro canto, si prevede che il segmento degli ospedali e dei centri trasfusionali registrerà il CAGR più elevato nei prossimi anni.

Approfondimenti strategici

Aziende che operano nel mercato della leucaferesi stanno adottando strategie come lanci di prodotti, fusioni e acquisizioni, collaborazioni, innovazioni di prodotto ed espansioni del portafoglio di prodotti per espandere la propria presenza in tutto il mondo, mantenere il marchio e soddisfare la crescente domanda da parte degli utenti finali.

< p> 

Mercato della leucaferesi: – per tipo di prodotto

  • Dispositivi per leucoaferesi
    • Dispositivi per aferesi
    • Colonne per leucaferesi e separatori cellulari
    • Filtri per leucoriduzione
    • Articoli monouso per leucaferesi

    Mercato della leucoaferesi - per applicazione

    • Applicazioni di ricerca
    • Applicazioni terapeutiche

    Mercato della leucaferesi - per utente finale

    • Aziende farmaceutiche e biotecnologiche
    • Istituti accademici e di ricerca
    • Fornitori di componenti del sangue e centri trasfusionali
    • Ospedali e Centri trasfusionali

    Mercato della leucaferesi: per area geografica

    • Nord America
      • Stati Uniti
      • Canada
      • Messico
    • < li>Europa
      • Francia
      • Germania
      • Italia
      • Regno Unito
      • Spagna
      • Resto dell'Europa
    • Asia Pacifico (APAC)
      • Cina
      • India
      • Corea del Sud
      • Giappone
      • Australia
      • Resto dell'Asia Pacifico
    • Medio Oriente e Asia Africa (MEA)
      • Sudafrica
      • Arabia Saudita
      • Emirati Arabi Uniti
      • Resto del Medio Oriente e dell'Africa. Africa
    • America del Sud (SAM)
      • Brasile
      • Argentina
      • Resto dell'America meridionale e centrale< /li>

    Profili aziendali

    • Asahi Kasei Corporation
    • Fresenius SE e Co. KGaA
    • Haemonetics Corporation
    • Terumo Corporation
    • STEMCELL Technologies Inc.
    • HemaCare
    • Macopharma
    • AllCells
    • STEMEXPRESS
    • BioIVT
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are leukapheresis?

Leukapheresis is a procedure that has white blood cells (leukocytes) involved in the body's immune response are segregated from a blood sample. It is a particular form of apheresis in which an element of blood, such as red blood cells or platelets, is obtained while the remaining blood is restored to circulation. Leukapheresis is often used to reduce very high white blood cell (WBC) counts, such as chronic blood cancers like chronic lymphocytic leukemia (CLL). It can also be completed to obtain white blood cells for later transplant, such as to manage abrupt declines in WBC counts throughout cancer chemotherapy. Another use is as a section of a novel form of immunotherapy, termed chimeric antigen receptor (CAR) T-cell therapy, to help fight leukemia, prostate cancer, and other forms of cancers. Leukapheresis can be completed on the person claiming treatment (autologous apheresis) or on a donor for a later transplant (allogeneic apheresis). Currently, leukapheresis is commonly used to treat various diseases, and it is also used for diagnostic purposes as it can increase circulating tumor cells yields.

What are the driving factors for the leukapheresis market across the globe?

Key factors that are driving the growth of this market are number of voluntary blood donors, increasing incidence of hematologic diseases, surge in elderly population and growing demand for leukopaks in clinical research activities boost the market growth over the years.

Which product type led the leukapheresis market?

The leukapheresis disposables segment dominated the global leukapheresis market and held the largest revenue share of 61.43% in 2021.

Which end-user held the largest share in the leukapheresis market?

The blood component providers and blood centers segment dominated the global leukapheresis market and accounted for the largest revenue share of 35.03% in 2021.

Who are the key players in the leukapheresis market?

The leukapheresis market majorly consists of the players such Asahi Kasei Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation Terumo Corporation, STEMCELL Technologies Inc., HemaCare, Macopharma, AllCells, STEMEXPRESS, and BioIVT amongst others.

What is the regional market scenario of leukapheresis?

Global leukapheresis market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for leukapheresis. The growth of the region is attributed to increasing product launches coupled with increasing patient population.
The Asia Pacific region is expected to account for the fastest growth in the leukapheresis market. Increase in government investments and a number of private biotechnology companies in this region contribute to this dominant share. The rising geriatric population and increasing investment in research are said to be responsible for this growth.

The List of Companies - Leukapheresis Market

  1. Asahi Kasei Corporation
  2. Fresenius SE & Co. KGaA
  3. Haemonetics Corporation
  4. Terumo Corporation
  5. STEMCELL Technologies Inc.
  6. HemaCare
  7. Macopharma
  8. AllCells
  9. STEMEXPRESS
  10. BioIVT

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports